MarkAMorganMD
Obstetrics & Gynecology • Philadelphia, PAGeneral Gynecology, Gynecologic Oncology
Chief of Gynecologic Oncology, University of Pennsylvania Health System
Dr. Morgan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-662-3318- Is this information wrong?
Summary
- Dr. Mark Morgan is an obstetrician/gynecologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Pennsylvania Hospital, Chester County Hospital, and Hospital of the University of Pennsylvania. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 35 years. He specializes in general gynecology and gynecologic oncology and is experienced in hereditary breast/ovarian cancer, squamous cell carcinoma of the cervix, familial breast/ovarian cancer, general obstetrics and gynecology, and supracervical hysterectomy.
Education & Training
University of Pennsylvania Health SystemFellowship, Gynecologic Oncology, 1986 - 1988- University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 1982 - 1986
State University of New York Downstate Medical Center College of MedicineClass of 1982
Certifications & Licensure
NJ State Medical License 2010 - 2025
PA State Medical License 1984 - 2024- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2003 Apr 01
- Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2004 Jun 01
Publications & Presentations
PubMed
- Facility level variation in the utilization of neoadjuvant chemotherapy is associated with higher surgical morbidity for patients with advanced stage epithelial ovaria...Nawar A Latif, Emily M Ko, Lori Cory, Sarah H Kim, Fiona Simpkins, Mark A Morgan, Robert L Giuntoli 2nd, Nasioudis, D.> ;Gynecologic Oncology. 2023 Feb 1
- 3 citationsA prospective cross-sectional survey comparing patient and provider expectations regarding ovarian cancer prognosis.Sarah P Huepenbecker, Xiaochen Zhang, Mark A Morgan, Ashley F Haggerty> ;Gynecologic Oncology Reports. 2022 Aug 1
- 97 citationsA Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov...Bradley J Monk, Christine Parkinson, Myong Cheol Lim, David M O'Malley, Ana Oaknin, Michelle K Wilson, Robert L Coleman, Domenica Lorusso, Paul Bessette, Sharad Ghaman...> ;Journal of Clinical Oncology. 2022 Dec 1
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
- Society of Pelvic SurgeonsMember
Hospital Affiliations
Pennsylvania HospitalPhiladelphia, Pennsylvania
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Penn Medicine Princeton Medical CenterPlainsboro, New Jersey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
